Anti-RAB9B/ RAB9L/ Rab-9L monoclonal antibody

Anti-RAB9B/ RAB9L/ Rab-9L antibody for FACS & in-vivo assay

Target products collectionGo to RAB9B/RAB9B products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP2586-Ab-1/ GM-Tg-hg-MP2586-Ab-2Anti-Human RAB9B monoclonal antibodyHuman
GM-Tg-rg-MP2586-Ab-1/ GM-Tg-rg-MP2586-Ab-2Anti-Rat RAB9B monoclonal antibodyRat
GM-Tg-mg-MP2586-Ab-1/ GM-Tg-mg-MP2586-Ab-2Anti-Mouse RAB9B monoclonal antibodyMouse
GM-Tg-cynog-MP2586-Ab-1/ GM-Tg-cynog-MP2586-Ab-2Anti-Cynomolgus/ Rhesus macaque RAB9B monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP2586-Ab-1/ GM-Tg-felg-MP2586-Ab-2Anti-Feline RAB9B monoclonal antibodyFeline
GM-Tg-cang-MP2586-Ab-1/ GM-Tg-cang-MP2586-Ab-2Anti-Canine RAB9B monoclonal antibodyCanine
GM-Tg-bovg-MP2586-Ab-1/ GM-Tg-bovg-MP2586-Ab-2Anti-Bovine RAB9B monoclonal antibodyBovine
GM-Tg-equg-MP2586-Ab-1/ GM-Tg-equg-MP2586-Ab-2Anti-Equine RAB9B monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP2586-Ab-1/ GM-Tg-hg-MP2586-Ab-2; GM-Tg-rg-MP2586-Ab-1/ GM-Tg-rg-MP2586-Ab-2;
GM-Tg-mg-MP2586-Ab-1/ GM-Tg-mg-MP2586-Ab-2; GM-Tg-cynog-MP2586-Ab-1/ GM-Tg-cynog-MP2586-Ab-2;
GM-Tg-felg-MP2586-Ab-1/ GM-Tg-felg-MP2586-Ab-2; GM-Tg-cang-MP2586-Ab-1/ GM-Tg-cang-MP2586-Ab-2;
GM-Tg-bovg-MP2586-Ab-1/ GM-Tg-bovg-MP2586-Ab-2; GM-Tg-equg-MP2586-Ab-1/ GM-Tg-equg-MP2586-Ab-2
Products NameAnti-RAB9B monoclonal antibody
Formatmab
Target NameRAB9B
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-RAB9B benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species RAB9B/ RAB9L/ Rab-9L VLP (virus-like particle) (Products Developing)
    ORF Viral VectorpGMLV000607house mouse Rab9b Lentivirus plasmid
    ORF Viral VectorvGMLV000607house mouse Rab9b Lentivirus particle


    Target information

    Target IDGM-MP2586
    Target NameRAB9B
    Gene ID51209,319642,367915,698014,481003,101098851,511866,100053770
    Gene Symbol and Synonyms9330195C02Rik,Rab-9L,RAB9B,RAB9L,RGD1562951
    Uniprot AccessionQ9NP90
    Uniprot Entry NameRAB9B_HUMAN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000123570
    Target ClassificationN/A

    The target: RAB9B, gene name: RAB9B, also named as RAB9L, Rab-9L. This gene encodes a member of a subfamily of RAS small guanosine triphosphate (GTP)-binding proteins that regulate membrane trafficking. The encoded protein may be involved in endosome-to-Golgi transport. [provided by RefSeq, Jan 2010].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.